Somanetics starts shipment of new oximeter:
This article was originally published in Clinica
Executive Summary
Somanetics has commenced US delivery of its next-generation cerebral oximeter monitoring system. The INVOS claims to be able to monitor oxygen on both sides of the brain simultaneously and will be available for children and new-born babies when these uses have been approved. The company is marketing the product for use in operating theatres as well as post-anaesthetic and intensive care.